Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia

Molecular and Cellular Neuroscience

Volumn 56, Issue , 2013, Pages 148-158

  Downer, Eric J ^a   Johnston, Daniel G W ^b   Lynch, Marina A ^b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Dok; Glia; Inflammation; Innate immunity; TLR

Indexed keywords

ADAPTOR PROTEIN; DOWNSTREAM OF KINASE 1; DOWNSTREAM OF KINASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; INFLAMMATION; INNATE IMMUNITY; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AD; ALZHEIMER'S DISEASE; CENTRAL NERVOUS SYSTEM; CNS; DAMAGE-ASSOCIATED MOLECULAR PATTERNS; DAMPS; DOK; DOWNSTREAM OF KINASE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EMSA; ERK; EXTRACELLULAR SIGNAL-REGULATED KINASE; GLIA; GM-CSF; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HANKS' BALANCED SALT SOLUTION BUFFERED; HBSS; IFN; INFLAMMATION; INNATE IMMUNITY; INTERFERON; M-CSF; MACROPHAGE COLONY STIMULATING FACTOR; MAL; MAPK; MITOGEN-ACTIVATED PROTEIN KINASE; MS; MULTIPLE SCLEROSIS; MYD88; MYD88-ADAPTOR LIKE; MYELOID DIFFERENTIATION FACTOR 88; NF-ΚB; NUCLEAR FACTOR-ΚB; PAMPS; PARKINSON'S DISEASE; PATHOGEN-ASSOCIATED MOLECULAR PATTERNS; PATTERN RECOGNITION RECEPTORS; PD; PH; PLECKSTRIN HOMOLOGY; PPRS; PROTEIN TYROSINE KINASE; PTK; SH; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE; SIRNA; SLAM; SMALL INTERFERING RNA; SRC HOMOLOGY; TIR; TLR; TOLL-INTERLEUKIN-1 RECEPTOR; TOLL-INTERLEUKIN-1 RECEPTOR (TIR)-DOMAIN-CONTAINING ADAPTOR-INDUCING IFN-Β; TOLL-LIKE RECEPTOR; TRAM; TRIF; TRIF-RELATED ADAPTOR MOLECULE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ASTROCYTES; CELLS, CULTURED; DNA-BINDING PROTEINS; INFLAMMATION; INTERLEUKIN-6; LIPOPEPTIDES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICROGLIA; NF-KAPPA B; PHOSPHOPROTEINS; RNA-BINDING PROTEINS; TOLL-LIKE RECEPTOR 2;

BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 84878501021     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2013.04.007     Document Type: Article

References (46)

1. Agell N., Bachs O., Rocamora N., Villalonga P. Modulation of the Ras/Raf/MEK/ERK pathway by Ca(2+), and calmodulin. Cell. Signal. 2002, 14:649-654.
2. Akira S. Mammalian Toll-like receptors. Curr. Opin. Immunol. 2003, 15:5-11.
3. Anand P.K., Tait S.W., Lamkanfi M., Amer A.O., Nunez G., Pages G., Pouyssegur J., McGargill M.A., Green D.R., Kanneganti T.D. TLR2 and RIP2 pathways mediate autophagy of Listeria monocytogenes via extracellular signal-regulated kinase (ERK) activation. J. Biol. Chem. 2011, 286:42981-42991.
4. Aravalli R.N., Hu S., Rowen T.N., Palmquist J.M., Lokensgard J.R. Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J. Immunol. 2005, 175:4189-4193.
5. Aravalli R.N., Hu S., Lokensgard J.R. Inhibition of toll-like receptor signaling in primary murine microglia. J. Neuroimmune Pharmacol. 2008, 3:5-11.
6. Babcock A.A., Wirenfeldt M., Holm T., Nielsen H.H., Dissing-Olesen L., Toft-Hansen H., Millward J.M., Landmann R., Rivest S., Finsen B., Owens T. Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J. Neurosci. 2006, 26:12826-12837.
7. Beaulieu L.M., Lin E., Morin K.M., Tanriverdi K., Freedman J.E. Regulatory effects of TLR2 on megakaryocytic cell function. Blood 2011, 117:5963-5974.
8. Berger A.H., Niki M., Morotti A., Taylor B.S., Socci N.D., Viale A., Brennan C., Szoke J., Motoi N., Rothman P.B., Teruya-Feldstein J., Gerald W.L., Ladanyi M., Pandolfi P.P. Identification of DOK genes as lung tumor suppressors. Nat. Genet. 2010, 42:216-223.
9. Bowman C.C., Rasley A., Tranguch S.L., Marriott I. Cultured astrocytes express toll-like receptors for bacterial products. Glia 2003, 43:281-291.
10. Bsibsi M., Ravid R., Gveric D., van Noort J.M. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 2002, 61:1013-1021.
11. Carpino N., Wisniewski D., Strife A., Marshak D., Kobayashi R., Stillman B., Clarkson B. p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 1997, 88:197-204.
12. Clement J.F., Meloche S., Servant M.J. The IKK-related kinases: from innate immunity to oncogenesis. Cell Res. 2008, 18:889-899.
13. Downer E.J., Cowley T.R., Lyons A., Mills K.H., Berezin V., Bock E., Lynch M.A. A novel anti-inflammatory role of NCAM-derived mimetic peptide, FGL. Neurobiol. Aging 2010, 31:118-128.
14. Downer E.J., Clifford E., Gran B., Nel H.J., Fallon P.G., Moynagh P.N. Identification of the synthetic cannabinoid R(+)WIN55,212-2 as a novel regulator of IFN regulatory factor 3 activation and IFN-beta expression: relevance to therapeutic effects in models of multiple sclerosis. J. Biol. Chem. 2011, 286:10316-10328.
15. Du X., Fleiss B., Li H., D'Angelo B., Sun Y., Zhu C., Hagberg H., Levy O., Mallard C., Wang X. Systemic stimulation of TLR2 impairs neonatal mouse brain development. PLoS One 2011, 6:e19583.
16. Dye J.R., Palvanov A., Guo B., Rothstein T.L. B cell receptor cross-talk: exposure to lipopolysaccharide induces an alternate pathway for B cell receptor-induced ERK phosphorylation and NF-kappa B activation. J. Immunol. 2007, 179:229-235.
17. Farez M.F., Quintana F.J., Gandhi R., Izquierdo G., Lucas M., Weiner H.L. Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nat. Immunol. 2009, 10:958-964.
18. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C.A., Mansell A.S., Brady G., Brint E., Dunne A., Gray P., Harte M.T., McMurray D., Smith D.E., Sims J.E., Bird T.A., O'Neill L.A. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 2001, 413:78-83.
19. Grimm J., Sachs M., Britsch S., Di Cesare S., Schwarz-Romond T., Alitalo K., Birchmeier W. Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation. J. Cell Biol. 2001, 154:345-354.
20. Guo Y., Xiao P., Lei S., Deng F., Xiao G.G., Liu Y., Chen X., Li L., Wu S., Chen Y., Jiang H., Tan L., Xie J., Zhu X., Liang S., Deng H. How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim. Biophys. Sin. (Shanghai) 2008, 40:426-436.
21. Henry C.J., Huang Y., Wynne A., Hanke M., Himler J., Bailey M.T., Sheridan J.F., Godbout J.P. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J. Neuroinflammation 2008, 5:15.
22. Hoffmann O., Braun J.S., Becker D., Halle A., Freyer D., Dagand E., Lehnardt S., Weber J.R. TLR2 mediates neuroinflammation and neuronal damage. J. Immunol. 2007, 178:6476-6481.
23. Hughan S.C., Watson S.P. Differential regulation of adapter proteins Dok2 and Dok1 in platelets, leading to an association of Dok2 with integrin alphaIIbbeta3. J. Thromb. Haemost. 2007, 5:387-394.
24. Jones N., Dumont D.J. The Tek/Tie2 receptor signals through a novel Dok-related docking protein, Dok-R. Oncogene 1998, 17:1097-1108.
25. Kalinderi K., Bostantjopoulou S., Katsarou Z., Fidani L. TLR9 -1237 T/C and TLR2 -194 to -174 del polymorphisms and the risk of Parkinson's disease in the Greek population: a pilot study. Neurol. Sci. 2013, 34:679-682.
26. Latour S., Gish G., Helgason C.D., Humphries R.K., Pawson T., Veillette A. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat. Immunol. 2001, 2:681-690.
27. Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 2010, 58:253-263.
28. Lehnardt S., Lehmann S., Kaul D., Tschimmel K., Hoffmann O., Cho S., Krueger C., Nitsch R., Meisel A., Weber J.R. Toll-like receptor 2 mediates CNS injury in focal cerebral ischemia. J. Neuroimmunol. 2007, 190:28-33.
29. Lue H., Kapurniotu A., Fingerle-Rowson G., Roger T., Leng L., Thiele M., Calandra T., Bucala R., Bernhagen J. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell. Signal. 2006, 18:688-703.
30. Mashima R., Hishida Y., Tezuka T., Yamanashi Y. The roles of Dok family adapters in immunoreceptor signaling. Immunol. Rev. 2009, 232:273-285.
31. Medzhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., Janeway C.A. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 1998, 2:253-258.
32. Mihrshahi R., Brown M.H. Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling. J. Immunol. 2010, 185:7216-7222.
33. Mihrshahi R., Barclay A.N., Brown M.H. Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. J. Immunol. 2009, 183:4879-4886.
34. Moynagh P.N. TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol. 2005, 26:469-476.
35. Shinohara H., Inoue A., Toyama-Sorimachi N., Nagai Y., Yasuda T., Suzuki H., Horai R., Iwakura Y., Yamamoto T., Karasuyama H., Miyake K., Yamanashi Y. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling. J. Exp. Med. 2005, 201:333-339.
36. Smith A., Wang J., Cheng C.M., Zhou J., Weickert C.S., Bondy C.A. High-level expression of Dok-1 in neurons of the primate prefrontal cortex and hippocampus. J. Neurosci. Res. 2004, 75:218-224.
37. Suzu S., Tanaka-Douzono M., Nomaguchi K., Yamada M., Hayasawa H., Kimura F., Motoyoshi K. p56(dok-2) as a cytokine-inducible inhibitor of cell proliferation and signal transduction. EMBO J. 2000, 19:5114-5122.
38. Van Slyke P., Coll M.L., Master Z., Kim H., Filmus J., Dumont D.J. Dok-R mediates attenuation of epidermal growth factor-dependent mitogen-activated protein kinase and Akt activation through processive recruitment of c-Src and Csk. Mol. Cell. Biol. 2005, 25:3831-3841.
39. Vezzani A., Maroso M., Balosso S., Sanchez M.A., Bartfai T. IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures. Brain Behav. Immun. 2011, 25:1281-1289.
40. Vollmar P., Kullmann J.S., Thilo B., Claussen M.C., Rothhammer V., Jacobi H., Sellner J., Nessler S., Korn T., Hemmer B. Active immunization with amyloid-beta 1-42 impairs memory performance through TLR2/4-dependent activation of the innate immune system. J. Immunol. 2010, 185:6338-6347.
41. Wang L.Z., Tian Y., Yu J.T., Chen W., Wu Z.C., Zhang Q., Zhang W., Tan L. Association between late-onset Alzheimer's disease and microsatellite polymorphisms in intron II of the human toll-like receptor 2 gene. Neurosci. Lett. 2011, 489:164-167.
42. Yamanashi Y., Tamura T., Kanamori T., Yamane H., Nariuchi H., Yamamoto T., Baltimore D. Role of the rasGAP-associated docking protein p62(dok) in negative regulation of B cell receptor-mediated signaling. Genes Dev. 2000, 14:11-16.
43. Yasuda T., Shirakata M., Iwama A., Ishii A., Ebihara Y., Osawa M., Honda K., Shinohara H., Sudo K., Tsuji K., Nakauchi H., Iwakura Y., Hirai H., Oda H., Yamamoto T., Yamanashi Y. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. J. Exp. Med. 2004, 200:1681-1687.
44. Yasuda T., Bundo K., Hino A., Honda K., Inoue A., Shirakata M., Osawa M., Tamura T., Nariuchi H., Oda H., Yamamoto T., Yamanashi Y. Dok-1 and Dok-2 are negative regulators of T cell receptor signaling. Int. Immunol. 2007, 19:487-495.
45. Zhang S., Phillips J.H. Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activation. J. Leukoc. Biol. 2006, 79:363-368.
46. Zhang S., Cherwinski H., Sedgwick J.D., Phillips J.H. Molecular mechanisms of CD200 inhibition of mast cell activation. J. Immunol. 2004, 173:6786-6793.